PubMed COVID-19 Clinical Care

CONCLUSIONS: COVID-19 vaccine mRNA technology was a lesser understood topic than attitudes for knowing about other health topics. This finding suggests the need for physician intervention and that further education about COVID-19 vaccine mRNA

CONCLUSIONS: Health education ideally comes in a variety of ways. Hospitals used social media for this purpose less than health departments, and neither group increased such content during the COVID-19 pandemic even as evidence of racial disparities

The COVID-19 pandemic dramatically changed society's interactions with spaces and places. This is especially true for shelter residents who had greater perceived risks of contracting the virus, largely because of communal living. To understand how

CONCLUSIONS: These results suggest that SARS-CoV-2 is neurotropic, with deleterious consequences for the blood-brain barrier integrity and central nervous system cells, which could underlie neurological disorders following SARS-CoV-2 infection.

CONCLUSION: This study shows that an ITS approach in trend analysis is a valuable supplement to comparisons of before and after measures (with or without controlling seasonal effects). The findings provide evidence on how ED presentations for opioid

Glycopeptide antibiotics (vancomycin and teicoplanin) are usually used for the treatment of Staphylococcus epidermidis infections owing to their increased oxacillin resistance. However, S. epidermidis strains with decreased susceptibility to

CONCLUSIONS: With regard to multidimensional disorders of pwMS, a combined training protocol is recommended for pwMS.

CONCLUSION: Accurate estimates of the cumulative incidence of SARS-CoV-2 infection can inform the development of university risk mitigation protocols such as encouraging booster shots, extending mask mandates or reverting to online classes. It could

This is a retrospective study that evaluated the medical charts of prior patients who were admitted to a hospital with the coronavirus, to trace changes in their function-based capabilities after receiving inpatient rehabilitation. Data related to

CONCLUSION: In acute adult COVID-19 patients presenting within 5 days of symptom onset, leflunomide combined with symptomatic treatment reduced fever duration and viral shedding time.